Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
107M
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
68.1M
-
Shares change
-
-264K
-
Total reported value, excl. options
-
$321M
-
Value change
-
-$12.5M
-
Number of buys
-
57
-
Number of sells
-
-43
-
Price
-
$4.73
Significant Holders of MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) as of Q2 2022
114 filings reported holding MXCT - MAXCYTE, INC. - Common Stock, par value $0.01 per share as of Q2 2022.
MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.1M shares
of 107M outstanding shares and own 63.69% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (14M shares), BlackRock Inc. (5.66M shares), Vitruvian Partners LLP (5.04M shares), VANGUARD GROUP INC (3.4M shares), Holocene Advisors, LP (3.04M shares), BAMCO INC /NY/ (2.39M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (2.37M shares), MILLENNIUM MANAGEMENT LLC (2.36M shares), RIVER & MERCANTILE ASSET MANAGEMENT LLP (2.26M shares), and ArrowMark Colorado Holdings LLC (2.15M shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.